ENDRA Life Sciences (NDRA) Revenue & Revenue Breakdown
ENDRA Life Sciences Revenue Highlights
00
ENDRA Life Sciences Revenue by Period
ENDRA Life Sciences Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2024-12-31 | - | 100.00% |
| 2023-12-31 | - | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2019-12-31 | - | -100.00% |
| 2018-12-31 | $6.17K | -98.24% |
| 2017-12-31 | $351.62K | -31.80% |
| 2016-12-31 | $515.58K | -63.44% |
| 2015-12-31 | $1.41M | 152.09% |
| 2014-12-31 | $559.36K | - |
ENDRA Life Sciences generated - in revenue during NA 2024, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.
ENDRA Life Sciences Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2025-03-31 | - | -100.00% |
| 2024-12-31 | $211.60K | 100.00% |
| 2024-09-30 | - | 100.00% |
| 2024-06-30 | - | 100.00% |
| 2024-03-31 | - | -100.00% |
| 2023-12-31 | $428.41K | 100.00% |
| 2023-09-30 | - | 100.00% |
| 2023-06-30 | - | 100.00% |
| 2023-03-31 | - | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2022-09-30 | - | 100.00% |
| 2022-06-30 | - | 100.00% |
| 2022-03-31 | - | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2021-09-30 | - | 100.00% |
| 2021-06-30 | - | 100.00% |
| 2021-03-31 | - | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2020-09-30 | - | 100.00% |
| 2020-06-30 | - | 100.00% |
| 2020-03-31 | - | 100.00% |
| 2019-12-31 | - | 100.00% |
| 2019-09-30 | - | 100.00% |
| 2019-06-30 | - | 100.00% |
| 2019-03-31 | - | 100.00% |
| 2018-12-31 | - | 100.00% |
| 2018-09-30 | - | 100.00% |
| 2018-06-30 | - | -100.00% |
| 2018-03-31 | $6.17K | -9.87% |
| 2017-12-31 | $6.85K | -97.61% |
| 2017-09-30 | $287.00K | 396.78% |
| 2017-06-30 | $57.77K | 100.00% |
| 2017-03-31 | - | -100.00% |
| 2016-12-31 | $515.58K | 100.00% |
| 2016-09-30 | - | 100.00% |
| 2016-06-30 | - | 100.00% |
| 2016-03-31 | - | -100.00% |
| 2015-12-31 | $255.00K | -21.80% |
| 2015-09-30 | $326.08K | - |
ENDRA Life Sciences generated - in revenue during Q1 2025, up -100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
ENDRA Life Sciences Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| NAOV | NanoVibronix | $2.28M | $494.00K |
| AKAN | Akanda | $2.16M | $762.61K |
| MOVE | Movano | $1.01M | $103.00K |
| MYNZ | Mainz Biomed B.V. | $895.48K | $214.76K |
| BBLG | Bone Biologics | - | - |
| CNSP | CNS Pharmaceuticals | - | - |
| BJDX | Bluejay Diagnostics | - | - |
| AMIX | Autonomix Medical | - | - |
| NDRA | ENDRA Life Sciences | - | - |
| KTTA | Pasithea Therapeutics | - | - |